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Objectives This study was designed to evaluate contrast-enhanced ultrasound imaging of carotid atherosclerosis as a clini-
cal tool to study intraplaque neovascularization.
Background Plaque neovascularization is associated with plaque vulnerability and symptomatic disease; therefore, imaging
of neovascularization in carotid atherosclerosis may represent a useful tool for clinical risk stratification and
monitoring the efficacy of antiatherosclerotic therapies.
Methods Thirty-two patients with 52 carotid plaques were studied by standard and contrast-enhanced ultrasound imaging.
In 17 of these patients who underwent endarterectomy, the surgical specimen was available for histological de-
termination of microvessel density by CD31/CD34 double staining. Plaque echogenicity and degree of stenosis
at standard ultrasound imaging were evaluated for each lesion. Contrast-agent enhancement within the plaque
was categorized as absent/peripheral (grade 1) and extensive/internal (grade 2).
Results In the surgical subgroup, plaques with higher contrast-agent enhancement showed a greater neovascularization
at histology (grade 2 vs. grade 1 contrast-agent enhancement: median vasa vasorum density: 3.24/mm2 vs.
1.82/mm2, respectively, p  0.005). In the whole series of 52 lesions, echolucent plaques showed a higher de-
gree of contrast-agent enhancement (p  0.001). Stenosis degree was not associated with neovascularization at
histology or with the grade of contrast-agent enhancement.
Conclusions Carotid plaque contrast-agent enhancement with sonographic agents correlates with histological density of
neovessels and is associated with plaque echolucency, a well-accepted marker of high risk lesions, but it is unre-
lated to the degree of stenosis. Contrast-enhanced carotid ultrasound imaging may provide valuable information
for plaque risk stratification and for assessing the response to antiatherosclerotic therapies, beyond that pro-
vided by standard ultrasound imaging. (J Am Coll Cardiol 2008;52:223–30) © 2008 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.082w
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nasa vasorum are physiological structures that provide
ourishment to the vessel wall and play an important role in
oth early and advanced stages of atherosclerosis. They are
ormally present in the adventitia of most muscular and
onduit arteries and extend into the outer layer of the media
n larger vessels. The concept that vasa vasorum are involved
n the pathophysiology of atherosclerosis dates back to the
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ealthcare.a
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008, accepted February 12, 2008.ork of Köester (in 1876) (1), Winternitz (in 1938) (2), and
as revived by Barger and colleagues (in 1984) (3), who clearly
howed in post-mortem samples that coronary atherosclerotic
egments presented a rich vascular network extending from the
dventitia to the full thickness of media and intima.
In animal models, hyperplasia of vasa vasorum is an early
vent of hypercholesterolemia-induced atherosclerosis and
ppears to precede endothelial dysfunction (4). Accordingly,
uman pathological studies show neovascularization already
n type II and, more prominently, in type III atherosclerotic
laques (according to the American Heart Association
lassification) (5). Experimental studies also indicate that
eovascularization is necessary for plaque development, as
ngiogenesis inhibitors can reduce plaque growth (6).
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Ultrasound Imaging of Plaque Neovascularization July 15, 2008:223–30Plaque neovessels originate mainly
from the adventitia, less often
from the main vessel lumen (7),
and extension of vasa vasorum to
the full thickness of the media
and intima of atherosclerotic seg-
ments represents pathological
neovascularization.
Several pathological studies showed that a more extensive
laque neovascularization is associated with features of plaque
ulnerability and with clinically symptomatic disease (8–10).
The mechanisms by which vasa vasorum contribute to the
evelopment of plaque instability may be their role in
eukocyte recruitment and plaque hemorrhage. Endothelial
ells in plaque neovessels express more adhesion molecules
han those in the main arterial lumen, which favor leukocyte
ecruitment (11). Moreover, these microvessels are imma-
ure and fragile and thus prone to rupture and hemorrhage,
hich promote plaque instability and represent an impor-
ant source of free cholesterol from red blood cells mem-
ranes, with consequent macrophage infiltration and ne-
rotic core enlargement (12).
These findings stimulate the search for techniques suit-
ble for the study of human plaque neovascularization in
ivo. Particularly, direct imaging of vasa vasorum may allow
he assessment of the response to antiatherosclerotic thera-
ies and may improve carotid plaque risk stratification.
agnetic resonance imaging with gadolinium infusion has
een employed in humans to evaluate carotid plaque vasa
asorum, with a good agreement with histologic findings
13). More recently, contrast-enhanced ultrasound imaging
as been proposed for imaging of carotid vasa vasorum (14),
ut no comprehensive studies have yet been published. This
pproach takes advantage of the high spatial and temporal
esolution of vascular ultrasound imaging and of the prop-
rties of contrast-agent microbubbles, which behave as pure
ntravascular tracers (15). Therefore, we compared direct
isualization of neovascularization of carotid plaques by
ontrast-enhanced ultrasound imaging with histological
ndings subsequently obtained in surgical carotid speci-
ens. We also correlated plaque neovascularization, as-
essed by contrast-enhanced ultrasound imaging, with stan-
ard ultrasound imaging plaque characterization in terms of
chogenicity and degree of stenosis, including a larger series
f carotid lesions not subjected to endarterectomy.
ethods
atient population and study protocol. Between April
nd October of 2005, we enrolled 32 patients (27 males, age
9.9  8.1 years) in the study. The patients were selected
rom those admitted to the coronary care unit or to the
ascular surgery unit, who had a clinical indication to
tandard carotid ultrasound imaging. The examination was
equested either because they were referred for carotid
Abbreviations
and Acronyms
ICA  internal carotid
artery
IMT  intima media
thicknessndarterectomy or screened for carotid atherosclerosis after edmission for ischemic heart disease. Inclusion criteria were
t least 1 carotid atherosclerotic stenosis 30%, age 18
ears, and ability to provide an informed consent. Exclusion
riteria were hypersensitivity to albumin, blood-derived
roducts, or to the ultrasound imaging contrast agent; severe
ulmonary hypertension; possible pregnancy; previous ca-
otid surgery or angioplasty; and poor quality of the stan-
ard ultrasound imaging study.
Carotid color Doppler ultrasound was recorded in all
tudy patients, and then contrast-enhanced ultrasound im-
ging was performed by 2 of the researchers (S.C., M.M.).
n the enrolled patients who had a clinical indication for
arotid surgery, the surgical specimens were also collected.
he protocol was approved by our local ethical committee
nd all patients provided an informed consent.
tandard and contrast-enhanced carotid ultrasound im-
ging. Imaging was performed with a GE-Vivid 7 ultra-
ound machine (GE Healthcare, Chalfont St. Giles, United
ingdom), using a 7L probe, for both standard and
ontrast-enhanced studies. First, the carotid bifurcation was
maged bilaterally by B-mode ultrasound, color Doppler,
nd pulsed-wave Doppler, and the examination was digitally
tored for later review. Special care was taken to image and
ecord all distinct plaques seen at each side.
The patients were then submitted to contrast-enhanced
ltrasound imaging, with special attention to the previously
dentified lesions. The preset real-time, contrast-specific
maging modality (pulse inversion) was switched on and
mage settings adjusted to maximize contrast signal visual-
zation. A low mechanical index was employed (0.08 to 0.10).
erfluoropropane-filled albumin microspheres (Optison, GE
ealthcare) were used as a contrast agent. A vial of Optison
as diluted with saline up to 10 ml (Optison 3 ml  saline
ml) and then a 2-ml bolus was injected and repeated as
eeded. Good images could be obtained for about 2 min
fter each bolus. For a single examination, no more than 2
ials of Optison were used. The studies were digitally stored
or later analysis. The patients were observed for 30 min
efore returning to their wards.
Standard and contrast-enhanced images were reviewed
ffline by 2 readers (S.C., M.M.).
Each visible plaque was classified in terms of echogenicity
t standard imaging, according to a widely used classifica-
ion scheme (16): class I: uniformly echolucent, class II:
redominantly echolucent, class III: predominantly echo-
enic, class IV: uniformly echogenic, and class V: extensive
alcification with acoustic shadowing. The degree of steno-
is determined by a plaque was measured according to
urrent guidelines (17).
In contrast-enhanced images, all the plaques appear dark
nd hypoechoic (because of tissue signal suppression), and the
dventitia still appears as a bright echogenic line. Moving
right spots within the plaque or on its adventitial side were
onsidered to represent the contrast agent’s bubble signal
oming from plaque neovascularization. On the contrary, fixed
chogenic spots were considered to be strong tissue acoustic
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July 15, 2008:223–30 Ultrasound Imaging of Plaque Neovascularizationeflectors. For each plaque contrast-agent enhancement (neo-
ascularization) was categorized as follows: grade 1: no bubbles
ithin the plaque or bubbles confined to plaque adventitial side
nd/or shoulder; grade 2: bubbles reaching plaque core and/or
xtensive contrast-agent enhancement throughout the plaque.
his scale reflects the fact that plaque neovascularization
hould derive mainly from the adventitial vasa vasorum net-
ork and, therefore, progressively grow from the external layers
oward the plaque core. In case of disagreement between
eaders, a consensus was reached.
istologic sampling and immunohistochemical studies.
arotid endarterectomy was performed in each patient with
he eversion technique that consists in transecting the internal
arotid artery (ICA) at its origin at the carotid bulb, turning
nside out (i.e., everting) the ICA over the plaque, and
emoving the latter en bloc with no longitudinal transection.
fter fixation in 10% buffered formalin and decalcification, if
ecessary, the specimens were sliced transversely every 5 mm
fter, then embedded in paraffin and stained with Movat’s
entachrome stains. For each plaque, 3 to 5 sections were
xamined according to the extension of the plaque itself.
For each histologic sample, the cross-sectional image was
cquired by a CCD Nikon digital camera DS-Qil (Nikon
nstruments Inc., Melville, New York) connected to P4
BM computer S50 (IBM, Armonk, New York). For each
egment, the following histologic variables were evaluated:
) lumen area (L); 2) internal elastic lamina (IEL) area; and
) cross-sectional plaque area calculated as [IEL – L].
istologic areas were calculated using the program Scion
mage (Scion Corporation, Frederick, Maryland) manually
racing the perimeter of the different vessel components.
The immunohistochemical study was performed on serial
-m thick sections cut from paraffin blocks in order to
haracterize and quantitate the vascularization present
ithin the plaque using a double staining with CD31 (1:100
ilution, purchased from Dako, Glostrup, Denmark) and
D34 (1:4,000 dilution, Dako) antibodies cocktail with an
vernight incubation at 4°C, with diaminobenzidine as the
nal chromogen.
First-order vasa vasorum (running longitudinally along
he entire length of the carotid artery) and second-order
asa vasorum (running transversely around the vessel wall of
he artery) were identified on the histologic specimen. The
umber of first- and second-order vasa vasorum were
ounted at a magnification of 20 and related to the
ross-sectional plaque area based on the method previously
escribed (18). Two pathologists (A.M., G.S.) who were
linded to the clinical findings graded all histocytological
omponents of the plaques. Intraobserver agreement was
5%. For the entire vessel circumference, either an average
f 20 fields per section were counted or a number of
icroscopic fields until the standard error of the mean was
5% (19). The total number of vasa vasorum per square
illimeter was used for correlation with imaging data.
tatistical analysis. Continuous data are presented as
ean standard deviation or as median with minimum (min)
*nd maximum (max) if more appropriate (non-normal distri-
ution). Comparison of microvessel densities between groups
as done with the Mann-Whitney U test. The degree of
tenosis was categorized as 50%, 50% to 69%, 70%, and
hi-square analysis was used. The association between plaque
chogenicity and contrast-agent enhancement was evaluated
y chi-square analysis. The Fisher exact test was used when
ppropriate. Statistical analysis was performed with SPSS 11.0
oftware (SPSS Inc., Chicago, Illinois).
Multivariate logistic regression analysis was also per-
ormed in order to adjust for degree of stenosis. The
orrelation of the plaques within patient was taken into
ccount using the generalized estimation equation method.
his method was run with proc GENMOD of SAS version
.2 (SAS Institute, Cary, North Carolina).
esults
tandard carotid ultrasound imaging. Clinical character-
stics of the patient population are reported in Table 1. Among
he 32 patients enrolled, 16 had 2 to 3 separate plaques, as a
esult of multiple bilateral and/or ipsilateral disease; therefore,
total of 52 plaques were studied in the whole group (Table 2).
laques were evenly distributed among different echogenicity
lasses (I: 14%, class II: 21%, class III: 17%, class IV: 23%, class
: 25%). The majority of lesions determined a stenosis be-
ween 50% and 69%. Six patients had a recent (within 6
onths) neurological event consistent with carotid artery
istribution; 7 plaques were considered symptomatic because 1
atient had bilateral cerebrovascular events.
ontrast-enhanced carotid ultrasound imaging. The ex-
mination was well tolerated in all patients, and good
uality images were available for all the plaques identified by
tandard ultrasound imaging. After contrast agent injection,
he main arterial lumen was well opacified with contrast
gent for about 2 min. In nearly one-third of the cases,
linical Profile of the Whole Studyopul tion and of the Surgical Subgroup
Table 1 Clinical Profile of the Whole StudyPopulation and of the Surgical Subgroup
Patient Population
(n  32)
Surgical Subgroup
(n  17)
Clinical characteristics
Mean age  SD (yrs) 69.9  8.1 68.05  8.25
Male gender, n (%) 27 (84) 14 (82)
Symptomatic patients, n (%)* 6 (19) 3 (17)
Cardiovascular risk factors
Family history, n (%) 13 (40) 7 (41)
Overweight/obesity, n (%) 12 (37) 7 (41)
Dyslipidemia, n (%) 18 (56) 7 (41)
Hypertension, n (%) 24 (75) 12 (71)
Diabetes mellitus, n (%) 11 (34) 5 (29)
Active cigarette smoking, n (%) 9 (28) 5 (29)
History of CAD, n (%) 14 (44) 6 (35)
History of PAD, n (%) 12 (38) 6 (35)
Previous† TIA/stroke, n (%) 4 (13) 3 (18)Neurological symptoms within 6 months; †6 months.
CAD  coronary artery disease; PAD  peripheral artery disease; TIA  transient ischemic attack.
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Ultrasound Imaging of Plaque Neovascularization July 15, 2008:223–30ontrast-agent enhancement was extensive and/or reached
he inner regions of the plaque (grade 2 enhancement). In 2
ases, contrast-enhanced ultrasound imaging revealed ca-
otid plaque ulcerations that were not detected by previous
tandard ultrasound imaging. The examination was well
olerated and no adverse reactions were observed.
orrelation between histology and contrast-enhanced
arotid ultrasound imaging. In 17 patients, a surgical
arotid endarterectomy was performed according to the
eferring physician prescription, and therefore, histolog-
cal analysis was performed. Details of this subgroup of
atients are presented in Table 1. Surgical specimens
ere available for the plaque determining the narrowest
tenosis (Table 2); the corresponding plaque ultrasound
maging characteristics were matched with histology. The
edian number of vasa vasorum per square millimeter
as 2.13 (min: 0.96, max: 4.09). Plaques with more
ntense contrast-agent enhancement showed a signifi-
antly higher degree of neovascularization at histology
median vasa vasorum density: 3.24/mm2, min: 1.75/
m2, max: 4.09/mm2, in plaques with grade 2 contrast-
gent enhancement vs. density: 1.82/mm2, min: 0.96/
m2, max: 2.36/mm2, in plaques with grade 1 contrast-
gent enhancement, p  0.005) (Fig.1). There was no
ifference in vasa vasorum density between plaques de-
ermining a stenosis 70% or 70% (median vasa
asorum density: 2.13/mm2, min: 1.18/mm2, max: 4.09/
m2, in plaques 70% vs. density: 2.06/mm2, min:
.96/mm2, max: 3.38/mm2, in plaques 70%, p  0.50).
n example of the correlation between imaging and
istology is provided in Figures 2 and 3.
orrelation between standard and contrast-enhanced
ltrasound imaging. Echogenicity by standard ultrasound
maging and contrast-agent enhancement were correlated
or each of the 52 identified plaques. More echolucent
laques had a significantly higher degree of contrast-agent
nhancement compared with more echogenic ones (p 
ain Features of All Studiedarotid Plaques and of Surgical Lesions Only
Table 2 Main Features of All StudiedCarotid Plaques and of Surgical Lesions Only
All Plaques
(n  52)
Surgical Lesions
(n  17)
Plaque characteristics, n (%)
Stenosis 50% 13 (25) 0 (0)
Stenosis 50%–69% 24 (46) 9 (53)
Stenosis 70% 15 (29) 8 (47)
Plaque echogenicity, n (%)
Class I 7 (14) 1 (6)
Class II 11 (21) 6 (35)
Class III 9 (17) 3 (18)
Class IV 12 (23) 2 (12)
Class V 13 (25) 5 (29)
Degree of plaque neovascularization, n (%)
Grade 1 35 (68) 11 (64)
Grade 2 17 (32) 6 (36).001 by chi-square analysis for trend, see Fig. 4). Noignificant association was found between the degree of
tenosis and contrast-agent enhancement (the prevalence of
rade 2 contrast-agent enhancement in plaques determining
stenosis 50%, 50% to 69%, and 70% was 27%, 41%,
nd 27%, respectively, p  0.56). When plaques were
ategorized as echolucent (class I to II) or echogenic (class
II to V), a positive association between echolucency and
ore intense neovascularization was still present (p 0.001
y chi-square analysis, odds ratio: 11.6, 95% confidence
nterval: 3.0 to 45.4) and this association remained signifi-
ant even after correcting for degree of stenosis and ac-
ounting for correlation of plaques within patients (p 
.001). In the surgical subgroup, there was a trend for a
igher prevalence of intense contrast-agent enhancement in
ypoechoic lesions (62.5% of class I to II plaques had grade
contrast-agent enhancement vs. 37.5% of class III to V
laques), which did not reach statistical significance (p 
.15); moreover, there was no difference in histological
icrovessel density between echolucent and echogenic le-
ions (median vasa vasorum density: 2.21/mm2, min: 0.96/
m2, max: 3.66/mm2, in class I to II plaques vs. density:
.13/mm2, min: 1.18/mm2, max: 4.09/mm2, in class III to
plaques, p 1.00). Figure 5 and Online Video 1 show an
xample of an hypoechoic lesion with extensive (grade 2)
ontrast-agent enhancement.
iscussion
ur findings indicate that contrast-enhanced carotid ultra-
ound imaging appears a promising technique for the direct
isualization of intraplaque vasa vasorum in carotid arteries.
e have found a good correlation between vasa vasorum
Figure 1 Vessel Density at Histology According
to Plaque Contrast-Agent Enhancement
The density of vasa vasorum at histology (number per square millimeter) is
greater in plaques with grade 2 contrast-agent enhancement at ultrasound
imaging compared with those with grade 1.
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July 15, 2008:223–30 Ultrasound Imaging of Plaque Neovascularizationensity at histology and the degree of contrast-agent enhance-
ent by ultrasound imaging. In a larger group of plaques,
ncluding nonsurgical ones, we have also observed that neovas-
ularization assessed by contrast-agent enhancement is greater
n more echolucent lesions, but is unrelated to the degree of
tenosis. As plaque echolucency is a marker of high-risk lesions
20), this finding is in agreement with the concept that more
ulnerable plaques have a higher degree of neovascularization
8–10). To our knowledge, this is the first published
xtensive report making a direct comparison between
uantitative histology and contrast-enhanced ultrasound
maging on a series of surgical specimens and describing
he correlation between plaque echogenicity, degree of
tenosis, and contrast-agent enhancement.
Sonographic contrast agents have already been used in
arotid imaging to enhance blood flow signal from the main
rterial lumen and improve vessel wall delineation for the
easurement of intima media thickness (IMT) (21) and
egree of stenosis (22). Rajaram et al. (23) described for the
rst time the presence of contrast-agent enhancement in
arotid plaques as an unexpected finding during IMT mea-
urement studies and ascribed this phenomenon to plaque
eovascularization. Indeed, contrast-enhanced ultrasound im-
ging has already been used to study tissue perfusion in the
yocardium and other organs (24) and to study tumor angio-
enesis (25), supporting the concept that microbubbles seen
ithin the plaque are showing local neovascularization.
Figure 2 Plaque Without Contrast-Agent Enhancement Showing
Panel A shows a large, predominantly hypoechoic plaque, at the origin of the inter
sound imaging (B). Panel C shows the micrograph of 1 of the sections studied of
the inset in panel C. In the region nearby the fibrous cap, only a few newly formedontrast-agent microbubbles are pure intravascular tracers; therefore, they can only reach plaque tissue by vascular chan-
els. According to pathological studies, the large majority of
hese vessels do not originate from the main arterial lumen, but
rom the adventitia, where a network of vasa vasorum physi-
logically exists (7). Very recently, 2 papers have been pub-
ished on vasa vasorum imaging by contrast-enhanced ultra-
ound imaging. Vicenzini et al. (26) described the visualization
f contrast-agent microbubbles within carotid plaques as a
arker of vascularization, even though no systematic histolog-
cal validation was performed. Shah et al. (27) reported a good
orrelation between carotid contrast-enhanced ultrasound im-
ging of intraplaque neovascularization and a semiquantitative
istological score on surgical specimens. Our study is the first
ne to report a good correlation between quantitative histo-
ogical neovessel density and contrast-agent enhancement. The
trength of this association may also be underestimated, be-
ause microvessel density at pathology may be loosely corre-
ated to functional estimates of blood flow by imaging, partic-
larly for immature and irregular neovessels such as those
bserved in atherosclerotic lesions or neoplastic tissue (28).
In animal models of neoplastic tissue, direct comparison
etween histology and contrast-enhanced ultrasound imag-
ng with careful image superimposition has shown that
ontrast-enhanced ultrasound imaging correctly identified
ighly vascularized areas and that vessels between 32 and 99
m could be identified (29).
It is highly unlikely that our findings can be explained on
nt Neovascularization at Histology
rotid artery. No plaque enhancement can be detected by contrast-enhanced ultra-
rresponding plaque (Movat’s pentachrome staining, 0.5). Panel D represents
vessels CD31/34 positive are present (arrow, 10).Sca
nal ca
the co
smallhe basis of imaging artifacts. Only moving bright spots
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Ultrasound Imaging of Plaque Neovascularization July 15, 2008:223–30ithin the plaques were considered to be a sign of local
eovascularization, and fixed bright echoes were considered
o be strong tissue reflectors. With careful adjustment of
maging settings and contrast-specific modality, it is quite
asy to look for contrast-agent microbubbles within plaque
issue, because most of the plaque appears dark (tissue signal
s suppressed) except for the bright line of the adventitia.
Figure 3 Plaque With Grade 2 Contrast-Agent Enhancement Sh
Panel A shows 3 consecutive frames of contrast-enhanced ultrasound imaging of
plaque (grade 2 contrast-agent enhancement). Micrograph in panel B shows a car
approximately 60% of the plaque area (Movat’s pentachrome staining, 0.5). In th
numerous CD31/CD34 positive neovessels are present. It is worth noting the pres
small second-order vasa (arrows, 10).
Figure 4 Grade of Contrast-Agent
Enhancement According to Plaque Echogenicity
The proportion of plaques with grade 2 contrast-agent
enhancement (red) is greater in more echolucent plaques.aAnother important observation of our study is that
cholucent plaques show a greater contrast-agent enhance-
ent compared with echogenic ones. More echolucent
laques are known to have more vulnerable pathological
eatures and to bear a higher risk of cerebrovascular events
20,30,31). Plaque neovascularization was found to be more
xtensive in symptomatic and pathologically vulnerable
arotid plaques (8,9). In a series of carotid surgical speci-
ens, McCarthy et al. (10) found a close correlation
etween the number of plaque neovessels and clinical
anifestations; moreover, plaque hemorrhage and rupture
ere also associated with increased neovascularization. Our
bservation of a positive relationship between plaque
cholucency and contrast-agent enhancement is in agree-
ent with these reported studies, as higher risk lesions are
ikely to have a greater degree of neovascularization. Neo-
ascularization is extensive in diabetic atherosclerosis (32),
ut fibrocalcific plaques in diabetic patients are no longer
ascularized, suggesting that microvessel involution may be
marker for plaque stabilization (33). This is in accordance
ith our results showing less extensive neovascularization in
ore echogenic (i.e., more fibrocalcific) lesions.
The degree of stenosis was not a significant predictor of
ontrast-agent enhancement in our study. Hyperplasia of
asa vasorum and neovascularization in atherosclerosis may
e driven by hypoxia (34) caused by arterial wall thickening,
hich could be greater in more stenotic lesions, but this
oes not appear to be the only mechanism; inflammation
35) and activation of toll-like receptors probably represent
g Abundant Neovascularization at Histology
erosclerotic lesion in the carotid bulb, showing contrast microbubbles within the
morrhagic fibrocalcific plaque with an eccentric large necrotic core occupying
a of a thin fibrous cap (C, which represents the inset in B) nearby the atheroma,
of a large first-order vasa vasorum () with a thin vessel wall surrounded byowin
an ath
otid he
e are
encenother important pathway to promote angiogenesis in
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July 15, 2008:223–30 Ultrasound Imaging of Plaque Neovascularizationtherosclerotic lesions (36). Nevertheless, a larger study is
equired to assess the factors associated to the visualization
f plaque neovessels.
Given the low number of symptomatic patients included
n our study, we cannot draw any conclusion on the
ssociation between clinical manifestations and contrast-
gent enhancement, but this should be an area of further
esearch, as the noninvasive detection of neovascularization
ay represent an important tool in plaque characterization.
ighly vascularized lesions identified by contrast-enhanced
ltrasound imaging, even if determining only an interme-
iate degree of stenosis, could theoretically bear a more
evere risk of neurological events. Interestingly, plaque
cholucency does not correlate with histological density of
asa vasorum, suggesting that contrast-enhanced ultrasound
maging may identify among hypoechoic carotid lesions a
ubgroup of highly vascularized, potentially vulnerable
laques. Plaque neovascularization may also become an
mportant marker for assessing the result of antiathero-
clerotic therapies beyond IMT. Experimental studies
ave shown that plaque neovascularization can regress
nd that this can happen despite a persistently increased
rterial wall thickness (37); therefore, changes in neovas-
ularization could occur earlier than IMT reductions and
ontrast-enhanced ultrasound imaging could be able to
onitor this phenomenon in the clinical setting. Indeed,
einstein (14) has described a very interesting case of
egression of vasa vasorum after aggressive statin therapy
Figure 5 Hypoechoic Carotid Plaque With Extensive (Grade 2)
Panel A shows a hypoechoic plaque at the origin of internal carotid artery. After in
contrast-agent enhancement can be observed, represented by several bright spotsn a diabetic patient. ntudy limitations. Our study has several limitations. We
ave used a semiquantitative approach for the evaluation of
ontrast-agent enhancement; dedicated approaches for mi-
rovascular imaging may greatly facilitate image analysis. At
he time of this study, we cannot define all the factors, such
s dynamic regulation of local microcirculation, that influ-
nce the ability to visualize plaque neovessels beyond their
ensity. Similarly we cannot determine the dimensions of the
essels we specifically observe. Further studies are required to
onfirm our findings in different groups of patients and
ossibly in other vascular districts. Prospective clinical studies
re also needed to evaluate the potential impact of contrast-
nhanced ultrasound imaging of plaque neovascularization in
etermining the risk of cerebrovascular events and in monitor-
ng the effect of antiatherosclerotic therapies.
onclusions
arotid plaque contrast-agent enhancement with sono-
raphic agents correlates with histological density of neoves-
els and, therefore, is a promising tool to study plaque vasa
asorum in the clinical setting. Neovascularization assessed
y contrast-enhanced ultrasound imaging is associated with
laque echolucency, a well-accepted marker of high-risk
esions, and does not depend on the degree of stenosis.
cholucency by itself does not correlate with histological
ensity of vasa vasorum, suggesting that contrast-enhanced
ltrasound imaging may identify among hypoechoic carotid
esions a subgroup of highly vascularized, potentially vul-
rast-Agent Enhancement
of Optison (panels B to D) an extensive
the plaque itself (also see Online Video 1).Cont
jection
withinerable plaques. Contrast-enhanced carotid ultrasound im-
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ation, beyond the simple evaluation of stenosis and
chogenicity, and for the assessment of progression and
egression of atherosclerosis. Further studies are necessary to
valuate the potential clinical usefulness of carotid contrast-
nhanced ultrasound imaging to better stratify the risk of
erebrovascular events and to monitor the response to
ntiatherosclerotic therapy. (18)
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APPENDIXor an accompanying video, please see the online version of this article.
